Clinical significance of circulating microparticles for venous thrombo - embolism in cancer patients
Ay, C.; Pabinger, I.; Thaler, J. · Zeitschrift für Orthopädie und Unfallchirurgie · 2012 · Heft 02 · S. 127 bis 131
Bibliografische Angaben
Zusammenfassung
SummaryCancer patients have a four-to seven-fold increased risk to develop a venous thromboembolic event. Accumulating evidence from experimental and clinical studies indicates that microparticles (MPs), small procoagulant membrane vesicles that are defined by size and a negatively charged phosphatidylserine rich surface, play an important role in the pathogenesis of cancer-related venous thromboembolism (VTE). However, the clinical significance of MPs as a predictive biomarker for VTE in cancer patients has not been fully elucidated yet. This might be due to unresolved methodological problems and a lack of data…